Investment Thesis
Intuitive Surgical exhibits exceptional financial health with 66% gross margins, 30% operating margins, and strong 20.5% revenue growth, complemented by debt-free balance sheet and $808.6M free cash flow generation. Primary concern is net income declining 0.7% YoY despite strong revenue growth, indicating margin compression that requires monitoring.
Strengths
- Exceptional profitability: 66.1% gross margin and 29.6% net margin demonstrate strong pricing power and operational efficiency
- Robust cash generation: $808.6M free cash flow with 29.2% FCF margin provides financial flexibility for R&D and shareholder returns
- Fortress balance sheet: Debt-free with $2.0B cash, 4.61x current ratio, and $17.5B equity base ensures financial stability
- Solid topline growth: 20.5% YoY revenue increase to $2.8B demonstrates sustained market demand for core products
Risks
- Margin compression: Net income declined 0.7% YoY despite 20.5% revenue growth, signaling potential cost pressures or strategic investments eroding profitability
- Capital deployment efficiency: ROE of 4.7% and ROA of 4.1% despite 30%+ operating margins suggest large asset base may have limited operational leverage
- Earnings growth dependency: EPS growing 22.6% while net income declined indicates reliance on share buybacks rather than organic earnings expansion
Key Metrics to Watch
- Operating margin trend (currently 30.9%) - assess whether margin compression is temporary or structural
- Free cash flow sustainability and capital allocation priorities
- Gross margin by product segment to identify sources of profitability pressure
Financial Metrics
Revenue
2.8B
Net Income
821.5M
EPS (Diluted)
$2.28
Free Cash Flow
808.6M
Total Assets
20.1B
Cash
2.0B
Profitability Ratios
Gross Margin
66.1%
Operating Margin
30.9%
Net Margin
29.6%
ROE
4.7%
ROA
4.1%
FCF Margin
29.2%
Balance Sheet & Liquidity
Current Ratio
4.61x
Quick Ratio
3.59x
Debt/Equity
0.00x
Debt/Assets
12.5%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-29T13:25:23.451338 |
Data as of: 2026-03-31 |
Powered by Claude AI